April 16th 2022
Pharmacy specialists discuss quality initiatives for myeloproliferative neoplasms, highlighting the importance of patient-specific, informative care in polycythemia vera, essential thrombocythemia, and myelofibrosis.
December 17th 2021
Experts in gynecologic oncology review the use of PARP inhibitors in ovarian cancer with a primary focus of these agents as a frontline maintenance strategy.
December 6th 2021
June 23rd 2021
A panel of experts discuss several topics pertaining to best practices and the challenges in regard to prophylaxis in hemophilia A, including the role of prophylaxis, prophylactic therapy options, outpatient care factors, and economic considerations.
March 26th 2021
Madeline Camejo, PharmD, MS, Michael Epshteyn, PharmD, MSM, and Estela Trimino, PharmD, BCPS, provide insights into the best practices implemented within their institutions by health-system pharmacy to address challenges brought on by COVID-19 related to infection control, treatment, and vaccine rollout.
March 17th 2021
December 22nd 2020
July 28th 2020
April 23rd 2020
December 24th 2019
